Mode
Text Size
Log in / Sign up

Prediction models for postoperative atrial fibrillation in lung cancer surgery show moderate discriminative performance

Prediction models for postoperative atrial fibrillation in lung cancer surgery show moderate…
Photo by Joachim Schnürle / Unsplash
Key Takeaway
Interpret POAF prediction models cautiously due to high heterogeneity and limited external validation.

This systematic review and meta-analysis evaluated prediction models for postoperative atrial fibrillation (POAF) in patients undergoing surgical treatment for lung cancer. The analysis included 6 studies and assessed discriminative performance using the area under the curve (AUC). The pooled AUC across studies was 0.79 (95% CI: 0.71-0.87), suggesting moderate ability to distinguish patients who will develop POAF from those who will not. Individual study AUC values ranged from 0.72 to 0.89.

Substantial heterogeneity was observed (I2=98.7%), indicating considerable variability among the included studies. The authors noted methodological weaknesses and a lack of external validation as key limitations, which restrict the clinical applicability of these models. The overall risk of bias was assessed as high.

Given these limitations, clinicians should interpret the predictive performance cautiously. The models may not generalize well to different surgical populations or settings without further validation. Future research should focus on improving model robustness and external validation before integration into routine clinical practice.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundPostoperative atrial fibrillation (POAF) is a common and clinically significant complication following lung cancer surgery, associated with increased morbidity and mortality. Although numerous prediction models have been developed to estimate POAF risk, their overall performance and methodological quality remain unclear.MethodsA systematic review and meta-analysis were conducted in accordance with the PRISMA 2020 guidelines, and the protocol was registered with PROSPERO (CRD42025115874). Chinese and English databases were searched from their inception until 30 May 2024. Studies that developed or validated prediction models for postoperative atrial fibrillation (POAF) in patients with surgically treated lung cancer were included. Data were extracted using the CHARMS checklist and the risk of bias was assessed using PROBAST. A random-effects meta-analysis was performed to pool the discriminative performance of the eligible models, using the area under the curve (AUC).ResultsSix studies were included. Most models were developed using logistic regression, with age, sex, cardiovascular comorbidities and surgical factors being the most common predictors. Reported area under the curve (AUC) values ranged from 0.72 to 0.89. The pooled AUC was 0.79 (95% CI: 0.71–0.87), which indicates good overall discrimination. However, substantial heterogeneity was observed (I2 = 98.7%). Subgroup analysis with consistent outcome definitions showed reduced heterogeneity. All studies were judged to have a high overall risk of bias.ConclusionsCurrent POAF prediction models for lung cancer patients show acceptable discriminative ability but are limited by methodological weaknesses and lack of external validation, restricting their clinical applicability.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251158742, identifier CRD420251158742.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.